MA20316A1 - Compose antibiotique,procede pour le preparer et compositions les contenant - Google Patents

Compose antibiotique,procede pour le preparer et compositions les contenant

Info

Publication number
MA20316A1
MA20316A1 MA20540A MA20540A MA20316A1 MA 20316 A1 MA20316 A1 MA 20316A1 MA 20540 A MA20540 A MA 20540A MA 20540 A MA20540 A MA 20540A MA 20316 A1 MA20316 A1 MA 20316A1
Authority
MA
Morocco
Prior art keywords
same
preparing
compositions containing
antibiotic compound
antibiotic
Prior art date
Application number
MA20540A
Other languages
English (en)
Inventor
Veikko Marttila Esko
Antero Uotila Jakko
Lauri Antero Marvola Marti
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of MA20316A1 publication Critical patent/MA20316A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
MA20540A 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant MA20316A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
MA20316A1 true MA20316A1 (fr) 1985-10-01

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20540A MA20316A1 (fr) 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant

Country Status (38)

Country Link
US (1) US4599326A (fr)
JP (1) JPS60158197A (fr)
KR (1) KR900006237B1 (fr)
AT (1) AT386414B (fr)
AU (1) AU565688B2 (fr)
BE (1) BE901411A (fr)
BG (1) BG43189A3 (fr)
CA (1) CA1224461A (fr)
CH (1) CH666275A5 (fr)
CS (1) CS247191B2 (fr)
CY (1) CY1462A (fr)
DE (1) DE3500179A1 (fr)
DK (1) DK149776C (fr)
ES (1) ES8605818A1 (fr)
FI (1) FI77249C (fr)
FR (1) FR2557878B1 (fr)
GB (1) GB2152502B (fr)
HK (1) HK11590A (fr)
HU (1) HU196221B (fr)
IE (1) IE57967B1 (fr)
IL (1) IL73885A (fr)
IS (1) IS2968A7 (fr)
IT (1) IT1184304B (fr)
KE (1) KE3841A (fr)
LU (1) LU85721A1 (fr)
MA (1) MA20316A1 (fr)
MX (1) MX156277A (fr)
NL (1) NL8403979A (fr)
NO (1) NO160263C (fr)
NZ (1) NZ210606A (fr)
PH (1) PH22471A (fr)
PL (1) PL144349B1 (fr)
PT (1) PT79777B (fr)
RO (1) RO91262B (fr)
SE (1) SE461854B (fr)
SU (1) SU1410866A3 (fr)
YU (1) YU44485B (fr)
ZA (1) ZA8410143B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
WO2004004693A1 (fr) * 2002-07-05 2004-01-15 Collgegium Pharmaceutical Compositions pharmaceutiques empechant la consommation abusive d'opioides et d'autres drogues
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
RU2006118801A (ru) * 2003-10-31 2007-12-10 Алза Корпорейшн (Us) Композиции и лекарственные формы для усиления всасывания габапентина и прегабалина
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
EP1789075A4 (fr) 2004-08-25 2009-07-01 Uab Research Foundation Substances ameliorant l'absorption destinees a l'administration de medicaments
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
EP2158898A1 (fr) 2006-06-23 2010-03-03 Aegis Therapeutics LLC Stabilisation de compositions alkylglycosidiques et procédé correspondant
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP4286400A3 (fr) 2011-05-18 2024-06-05 Eumederis Pharmaceuticals, Inc. Agents pharmaceutiques peptidiques améliorés
EP2922877B1 (fr) 2012-11-20 2018-09-05 Eumederis Pharmaceuticals, Inc. Agents pharmaceutiques peptidiques améliorés
WO2014081872A1 (fr) 2012-11-20 2014-05-30 Mederis Diabetes, Llc Produits pharmaceutiques peptidiques améliorés pour la résistance à l'insuline
WO2014140699A1 (fr) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd Nouveau procédé de libération d'érythromycine et préparation de ses sels
CN117582516A (zh) 2014-05-28 2024-02-23 梅德瑞斯糖尿病有限责任公司 针对胰岛素抵抗的改良肽药物
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
JP6938682B2 (ja) 2017-05-19 2021-09-22 ルネラ・バイオテック・インコーポレーテッド アンチミトシン:癌幹細胞を根絶するためのミトコンドリア生合成の標的阻害薬
CA3083487A1 (fr) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins : inhibiteurs cibles de biogenese mitochondriale pour eradiquer les cellules souches cancereuses
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス,エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
ES2791775B2 (es) 2018-02-06 2023-01-20 Aegis Therapeutics Llc Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
PE20211551A1 (es) * 2018-12-17 2021-08-16 Lunella Biotech Inc Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas
CA3123850A1 (fr) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Tritherapies pour lutter contre le vieillissement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
AU565688B2 (en) 1987-09-24
FI77249B (fi) 1988-10-31
KE3841A (en) 1989-04-07
MX156277A (es) 1988-08-04
RO91262A (fr) 1987-06-30
ES539349A0 (es) 1986-04-01
NO160263B (no) 1988-12-19
LU85721A1 (fr) 1985-07-24
NO850007L (no) 1985-07-08
PT79777A (en) 1985-01-01
NZ210606A (en) 1987-08-31
SE8406671L (sv) 1985-07-07
IT1184304B (it) 1987-10-28
GB2152502B (en) 1987-10-07
IE850022L (en) 1985-07-06
AU3705984A (en) 1985-07-11
DK149776B (da) 1986-09-29
DK149776C (da) 1987-04-21
CS247191B2 (en) 1986-12-18
RO91262B (ro) 1987-07-01
IT8519012A0 (it) 1985-01-04
ATA985A (de) 1988-01-15
IL73885A0 (en) 1985-03-31
PL251457A1 (en) 1985-11-05
IS2968A7 (is) 1985-04-03
DK5884A (da) 1985-07-07
PT79777B (en) 1986-10-21
HK11590A (en) 1990-02-23
FI850023A0 (fi) 1985-01-03
ES8605818A1 (es) 1986-04-01
SE8406671D0 (sv) 1984-12-28
CH666275A5 (de) 1988-07-15
HU196221B (en) 1988-10-28
BG43189A3 (en) 1988-04-15
IE57967B1 (en) 1993-06-02
AT386414B (de) 1988-08-25
BE901411A (fr) 1985-04-16
SU1410866A3 (ru) 1988-07-15
FR2557878A1 (fr) 1985-07-12
JPH029040B2 (fr) 1990-02-28
IL73885A (en) 1988-10-31
YU44485B (en) 1990-08-31
CY1462A (en) 1989-07-21
PL144349B1 (en) 1988-05-31
NL8403979A (nl) 1985-08-01
SE461854B (sv) 1990-04-02
PH22471A (en) 1988-09-12
YU2085A (en) 1987-12-31
NO160263C (no) 1989-03-29
FI850023L (fi) 1985-07-07
FR2557878B1 (fr) 1988-01-15
GB2152502A (en) 1985-08-07
DK5884D0 (da) 1984-01-06
US4599326A (en) 1986-07-08
DE3500179C2 (fr) 1989-08-24
ZA8410143B (en) 1985-08-28
KR900006237B1 (ko) 1990-08-27
DE3500179A1 (de) 1985-07-18
JPS60158197A (ja) 1985-08-19
KR850005452A (ko) 1985-08-26
GB8432368D0 (en) 1985-02-06
FI77249C (fi) 1989-02-10
HUT37628A (en) 1986-01-23
CA1224461A (fr) 1987-07-21

Similar Documents

Publication Publication Date Title
FR2557878B1 (fr) Compose antibiotique, procede pour le preparer et compositions le contenant
AU585561B2 (en) New peptide-aldehydes, process for the preparation thereof and pharmaceutical compositions containing the same
PH21995A (en) Antibiotic compounds, their composition and process for the preparation of said compound
GB2171695B (en) Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
BE893010A (fr) Compose stable de sulfate de glucosamine, son procede de preparation et compositions pharmaceutiques les contenant
FI851269A0 (fi) Anlaeggning foer kontinuerlig pressning av en pressgodsmatta i samband med framstaellningen av spaonplattor, fiberplattor och liknande.
IL64345A (en) Substituted phenoxypropanolamine derivatives,process for the production thereof and pharmaceutical compositions containing the same
DE3167997D1 (en) Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same
FR2565227B1 (fr) 1,24-dihydroxy-22-vitamines d3 et procede pour les preparer
BE894527A (fr) Compositions pour composts
FR2554444B1 (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer
IL62960A0 (en) Imidazoazole compounds,their production and pharmaceutical compositions containing them
GB8429910D0 (en) Biochemical process & composition
FR2521135B1 (fr) Composes polyanioniques, procede pour les preparer et compositions les contenant
DK206482A (da) Vaekstmediesammensaetning
FR2519989B1 (fr) Monohydrates de steroides, formules en contenant et procede pour les preparer
PH16945A (en) Substituted triphenyl thiazole compounds,their pharmaceutical compositions and their use
FR2510129B1 (fr) Compose d'addition et son procede de preparation
HUT38537A (en) Process for producing pharmaceutical compositions containing peneme or carbapeneme antibiotics
PT77428B (fr) Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant
HUT40652A (en) Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds
DE3562370D1 (en) Amide compounds, process for preparing the same and pharmaceutical compositions containing the same
FR2549042B1 (fr) Procede pour la preparation de la 3,11-dimethyl-2-nonacosanone
PT72625B (en) Process for the preparation of 1-(3,5-diclorobenzoyl)-3-phenyl-pyrazolines having mildenicide effect
AU547585B2 (en) Arthritis composition of matter, and methods of preparing andutilizing same